Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment-Reference-Cited by-同舟云学术

Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment

Published:2018-04 Issue: Volume:230 Page:118-124
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Lin Chun-Yuan,Lai Te-Jen,Wu Yu-Hsin,Chen Ping-Kun,Lin Yuan-Fu,Chien I.-Chia

Funder

Hospital and Social Welfare Organizations Administration Commission

Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference43 articles.

1. Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression;Alexopoulos;Am. J. Geriatr. Psychiatry,2008

2. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability;Alexopoulos;Arch. Gen. Psychiatry,2011

3. American Psychiatric Association, 2010. Practice guideline for the treatment of patients with major depressive disorder. 3rd edition. Arlington, VA.

4. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder;Bauer;J. Affect. Disord.,2010

5. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study;Bauer;J. Clin. Psychiatry,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with antipsychotic use in non-psychotic depressed patients: results from a clinical multicenter survey;BMC Psychiatry;2022-02-03

2. Corrigendum to “Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment” [J. Affect. Disord. 230(1) (2018) 118–124];Journal of Affective Disorders;2018-07